Cerebellar transcranial magnetic stimulation to treat drug‐resistant epilepsy: A randomized, controlled, crossover clinical trial
This trial suggested that cTBS targeting the cerebellum was effective and well tolerated in the treatment of DRE. Further studies are warranted to confirm its effectiveness and mechanism.
Authors
- Changgeng Song (ORCID: https://orcid.org/0000-0002-7689-5731)
- Fang Yuan (ORCID: https://orcid.org/0000-0002-4050-7362)
- Xiaojing Shi (ORCID: https://orcid.org/0000-0001-6303-3676)
- Lang Jin
- Xiuxiu Leng
- Yuan Yuan Wang (ORCID: https://orcid.org/0000-0002-2141-4056)
- Duolao Wang (ORCID: https://orcid.org/0000-0003-2788-2464)
- Lei Ma
- Zhongqing Sun
- Ling Wang
- Yü Liu (ORCID: https://orcid.org/0000-0003-2211-3535)
- Wen Jiang (ORCID: https://orcid.org/0000-0003-0612-2917)
- Dian‐Wei Wu
- L. Shang (ORCID: https://orcid.org/0000-0002-9218-2408)
- Jingjing Zhao (ORCID: https://orcid.org/0000-0002-2000-6640)
- Jian‐Min Hao
Institutions
- Guangzhou University of Chinese Medicine (CN)
- Liverpool School of Tropical Medicine (GB)
- Xijing Hospital (CN)
- Air Force Medical University (CN)
Publication Details
- Journal
- Epilepsia
- Published
- 2024-11-08
- DOI
- https://doi.org/10.1111/epi.18168
- Citations
- 8
- Primary Topic
- Transcranial Magnetic Stimulation Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.98
Funders
- National Natural Science Foundation of China